Evidence map›Paper›PMID 32534848›Full record

Observational studyObesity research & clinical practice

Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding.

Diego Moriconi, Stefano Masi, Eleni Rebelos, Agostino Virdis, Maria Laura Manca, Salvatore De Marco, Stefano Taddei, Monica Nannipieri

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Obesity research & clinical practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 5 pooled it
3.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 5 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. SARS-CoV-2 Infection Alters the Phenotype and Gene Expression of Adipocytes.International journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Ct,Future science OA · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Diego MoriconiDepartment of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: d.moriconi@ao-pisa.toscana.it.
Stefano MasiDepartment of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: stefano.masi@unipi.it.
Eleni RebelosDepartment of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: elenirebelos@gmail.com.
Agostino VirdisDepartment of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: agostino.virdis@unipi.it.
Maria Laura MancaDepartment of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: l.manca@med.unipi.it.
Salvatore De MarcoAzienda Ospedaliero Universitaria Pisa, AOUP, Pisa, Italy. Electronic address: s.demarco@ao-pisa.toscana.it.
Stefano TaddeiDepartment of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: stefano.taddei@unipi.it.
Monica NannipieriDepartment of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: monica.nannipieri@dmi.unipi.it.
University of Pisa · ITAzienda Ospedaliera Universitaria Pisana · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOn the last three months the new SARS-COV-2 coronavirus has created a pandemic, rapidly spreading all around the world. The aim of the study is to investigate whether obesity impacts on COVID-19 morbidity.

methodsOne hundred consecutive patients with COVID-19 pneumonia admitted in our Medical Unit were evaluated. Anthropometric parameters and past medical history were registered. Nasopharyngeal swab samples and biochemical analysis were obtained at admission and during hospital stay.

resultsPatients with (OB, 29) and without obesity (N-OB, 71) were similar in age, gender and comorbidities, with the exception of hypertension that was more frequent in OB group. At admission, inflammatory markers were higher in OB than N-OB group. OB group showed a worse pulmonary clinical picture, with lower PaO2 (57 ± 15 vs. 68 ± 14 mmHg, p = 0.042), and SaO2 (88 ± 6 vs. 92 ± 5%, p = 0.049) at admission consequently requiring higher volumes of oxygen (Fi02: 38 ± 15 vs. 29 ± 19%, p = 0.047) and a longer period to achieve oxygen weaning (10 ± 6 vs. 15 ± 7 days, p = 0.03). OB group also had positive swabs for longer time (19 ± 8 vs. 13 ± 7, days, p = 0.002), and required longer hospital stay (21 ± 8 vs. 13 ± 8, days, p = 0.0008). Partial least square regression analysis showed that BMI, age and CRP at admission were related to longer length of hospital stay, and time for negative swab. On the contrary, in this cohort, obesity did not predict higher mortality.

conclusionsSubjects with obesity affected by COVID-19 require longer hospitalization, more intensive and longer oxygen treatment, and they may have longer SARS-COV-2 shedding.

Indexed as

BetacoronavirusAgedCohort StudiesCoronavirus InfectionsCOVID-19FemaleHumansItalyLength of StayMaleObesityPandemicsPneumonia, ViralRetrospective StudiesSARS-CoV-2Virus SheddingCitokynesCOVID-19CRPObesityViral shedding

Identifiers

PMID32534848
PMCPMC7269944
OpenAlexW3034107850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.